Immunology and Microbiology
Escherichia coli
47%
Salmonella
32%
Plasmid
31%
Antimicrobial Resistance
29%
Epstein Barr Virus
28%
Colistin
28%
Mouse
25%
Klebsiella pneumoniae
24%
Feline Immunodeficiency Virus
23%
Infectious Agent
23%
Retrovirus
20%
Mason-Pfizer Monkey Virus
20%
Cancer Cell
19%
Immunotherapy
19%
Enterobacterales
19%
Immune System
16%
Mouse Mammary Tumor Virus
14%
Immune Response
14%
Viral Disease
14%
Subgingival Microbiome
14%
Leadership
13%
Antimicrobial Resistance
12%
Microflora
11%
Binding Site
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Coronavirinae
11%
Autoimmune Diabetes
11%
Salmonella Enterica Serovar Typhimurium
11%
Microbiome
11%
Low Drug Dose
10%
Acylation
10%
Multiple Sclerosis
10%
T Cell
10%
Prevalence
10%
Exosome
10%
Disease Burden
9%
Whole Genome Sequencing
9%
Rabbit Model
9%
Regulatory T Cell
9%
Untranslated Region
9%
CD154
9%
Bioenergy
9%
Simian Immunodeficiency Virus
9%
Antiinflammatory Activity
9%
Cladistics
9%
Broiler
9%
Dimerization
9%
Homeostasis
9%
Monoclonal Antibody
9%
Cytotoxicity
8%
Long Terminal Repeat
8%
Periodontitis
8%
B Cell
8%
Gut Microbiome
7%
COVID-19
7%
Oral Microbiome
7%
Interleukin-6
7%
One Health
7%
Cell Line
7%
Human Immunodeficiency Virus
7%
Vaccine Efficacy
7%
Polymerase Chain Reaction
7%
Wound Healing
7%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
7%
Immunofluorescence
7%
C3H/He Mouse
7%
Virion
6%
Viral Replication
6%
Galectin 3
6%
Electrical Parameters
6%
Innate Immune System
6%
Enterobacteriaceae
6%
Microorganism
6%
Camel
6%
Cancer Cell Line
6%
Life Cycle
6%
Biofilm
6%
Cells of the Immune System
5%
Intravenous Immunoglobulin
5%
Salmonella enterica
5%
Myeloid
5%
TLR4
5%
Phylogeny
5%
Macrophage
5%
Human Immunodeficiency Virus 1
5%
STAT3
5%
Interleukin 11
5%
in Situ Hybridization
5%
Immunoglobulin Class Switching
5%
Promoter Region
5%
Functional Status
5%
RNA Vector
5%
Antibiotic Sensitivity
5%
Multidrug Resistance
5%
Medicine and Dentistry
Global Disease Burden
100%
Malignant Neoplasm
31%
Disability Adjusted Life Years
31%
Human Immunodeficiency Virus
28%
Disease
25%
Mortality Rate
19%
Life Expectancy
18%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Injury
17%
COVID-19
15%
Breast Cancer
12%
Respiratory Tract Infection
11%
Antibiotic Resistance
11%
Cancer Incidence
11%
Tumor Microenvironment
11%
Coronavirinae
11%
Cohort Effect
10%
Epstein Barr Virus
9%
Cancer
9%
Geographic Mapping
9%
Demography
9%
Neoplasm
9%
Prevalence
9%
Infection
8%
In Vitro
8%
Gut Microbiome
8%
Cancer Growth
7%
Diarrhea
7%
Toddlers
7%
Microbiome
6%
Disease Burden
6%
Cancer Therapy
6%
Health System
6%
Diabetes
6%
HIV/AIDS
6%
Systematic Review
5%
Immune Response
5%
Diabetes Mellitus
5%
Retrospective Study
5%
Gut
5%
Health Care
5%
Tumor Immune Microenvironment
5%
Health Outcomes
5%
Upper Respiratory Tract Infection
5%
Bacterial Infection
5%
Insulin Dependent Diabetes Mellitus
5%
Liver Cancer
5%
Cancer Mortality
5%
Acute Disease
5%
Keyphrases
Global Burden of Disease Study
34%
Mortality Rate
15%
Global Burden of Disease 2019
14%
Disability-adjusted Life Years
13%
Global Burden of Disease
13%
Socio-demographic Index
12%
Global Occurrence
11%
Disease Factor
11%
Injury Factors
11%
Risk Factor Study
11%
Sex-specific
11%
Life Expectancy
11%
Children Younger than 5 Years
10%
Under-five Mortality
10%
Uncertainty Interval
10%
Risk Factors
9%
Sub-Saharan Africa
9%
Age Groups
9%
Metabolic Clusters
9%
Comparative Risk Assessment
9%
Occupational Risk
9%
Metabolic Risk Factors
9%
Virus RNA
9%
Mason-Pfizer Monkey Virus
9%
Incidence Prevalence
9%
National Incidence
9%
Epstein-Barr Virus
9%
Outer Membrane Permeabilization
9%
Virus Detection
9%
Histological Samples
9%
Cefiderocol
9%
Tobacco Varieties
9%
Subgingival Microbiota
9%
Periodontal Health
9%
5′-untranslated Region (5′-UTR)
8%
Lower Respiratory Infections
8%
Multiple Sclerosis
7%
Gag Gene
7%
Adult Mortality
7%
Risk Exposure
6%
Vital Registration
6%
Exposure Level
6%
Diabetes
6%
AIDS/HIV
6%
Death Rate
6%
GBD 2019
5%
Encapsidation
5%
Years Lived with Disability
5%
Population Estimate
5%
Live Birth
5%
Immune System
5%
Cause of Death
5%
Sex-specific Mortality
5%
Incident Cases
5%
GBD 2017
5%
Birth History
5%
Pregenomic RNA (pgRNA)
5%
Signaling Molecules
5%
Immunomodulatory Effect
5%
Epstein-Barr Virus Infections
5%
Age Estimation
5%
Age-adjusted Mortality Rates
5%
Regional Burden
5%
Under-five
5%